Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid-Reference-Cited by-同舟云学术

Comparison of the in vitro effect of eicosapentaenoic acid (EPA)-derived lipoxygenase metabolites on human platelet function with those of arachidonic acid

Published:1986-02 Issue:3 Volume:41 Page:373-384
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Takenaga M.,Hirai A.,Terano T.,Tamura Y.,Kitagawa H.,Yoshida S.

Publisher

Elsevier BV

Subject

Hematology

Reference26 articles.

1. The role of prostaglandin endoperoxides and thromboxanes as bioregulators;Samuelsson,1977

2. Mechanism of anti-platelet aggregating action of Dilazep;Takenaga;J. Pharmacobio-Pyn.,1985

3. Regulation of arachidonate-induced platelet aggregation by the lipoxygenase product, 12-hydroperoxyeicosatetraenoic acid;Aharony;Biochim. Biophys. Acta,1982

4. Regulation of arachidonate metabolism via lipoxygenase and cyclooxygenase by 12-HPETE, the product of human platelet lipoxy genase;Siegel;Biochem. Biophys. Res. Commun.,1979

5. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis?;Dyerberg;Lancet,1978

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactive lipid regulation of platelet function, hemostasis, and thrombosis;Pharmacology & Therapeutics;2023-06

2. Accumulation of polyunsaturated fatty acid‐derived metabolites in the sarcopenic muscle of aging mice;Geriatrics & Gerontology International;2023-02-22

3. Oxylipin status, before and after LC n-3 PUFA supplementation, has little relationship with skeletal muscle biology in older adults at risk of sarcopenia;Prostaglandins, Leukotrienes and Essential Fatty Acids;2023-02

4. Role of cytochrome P450-epoxygenase and soluble epoxide hydrolase in the regulation of vascular response;Bioactive Lipid Mediators in Cardiopulmonary Pharmacology;2023

5. Crosstalk between adenosine receptors and CYP450-derived oxylipins in the modulation of cardiovascular, including coronary reactive hyperemic response;Pharmacology & Therapeutics;2022-12